As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and their long-term focus allows us to profit from the recent declines. In particular, let’s take a look at what hedge funds think about Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) in this article. Is Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) a healthy stock for your portfolio? Prominent investors are turning bullish.